Title : bPiDI: a novel selective alpha6beta2* nicotinic receptor antagonist and preclinical candidate treatment for nicotine abuse - Wooters_2011_Br.J.Pharmacol_163_346 |
Author(s) : Wooters TE , Smith AM , Pivavarchyk M , Siripurapu KB , McIntosh JM , Zhang Z , Crooks PA , Bardo MT , Dwoskin LP |
Ref : British Journal of Pharmacology , 163 :346 , 2011 |
Abstract : |
PubMedSearch : Wooters_2011_Br.J.Pharmacol_163_346 |
PubMedID: 21232049 |
Title : Repeated nicotine administration robustly increases bPiDDB inhibitory potency at alpha6beta2-containing nicotinic receptors mediating nicotine-evoked dopamine release - Smith_2010_Biochem.Pharmacol_80_402 |
Author(s) : Smith AM , Pivavarchyk M , Wooters TE , Zhang Z , Zheng G , McIntosh JM , Crooks PA , Bardo MT , Dwoskin LP |
Ref : Biochemical Pharmacology , 80 :402 , 2010 |
Abstract : |
PubMedSearch : Smith_2010_Biochem.Pharmacol_80_402 |
PubMedID: 20346923 |
Title : Nicotinic receptor-based therapeutics and candidates for smoking cessation - Dwoskin_2009_Biochem.Pharmacol_78(7)_732 |
Author(s) : Dwoskin LP , Smith AM , Wooters TE , Zhang Z , Crooks PA , Bardo MT |
Ref : Biochemical Pharmacology , 78 :732 , 2009 |
Abstract : |
PubMedSearch : Dwoskin_2009_Biochem.Pharmacol_78(7)_732 |
PubMedID: 19523455 |
Title : N,N'-Alkane-diyl-bis-3-picoliniums as nicotinic receptor antagonists: inhibition of nicotine-evoked dopamine release and hyperactivity - Dwoskin_2008_J.Pharmacol.Exp.Ther_326_563 |
Author(s) : Dwoskin LP , Wooters TE , Sumithran SP , Siripurapu KB , Joyce BM , Lockman PR , Manda VK , Ayers JT , Zhang Z , Deaciuc AG , McIntosh JM , Crooks PA , Bardo MT |
Ref : Journal of Pharmacology & Experimental Therapeutics , 326 :563 , 2008 |
Abstract : |
PubMedSearch : Dwoskin_2008_J.Pharmacol.Exp.Ther_326_563 |
PubMedID: 18460644 |